These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23127333)

  • 1. The inhibition of human bladder cancer growth by calcium carbonate/CaIP6 nanocomposite particles delivering AIB1 siRNA.
    Wei J; Cheang T; Tang B; Xia H; Xing Z; Chen Z; Fang Y; Chen W; Xu A; Wang S; Luo J
    Biomaterials; 2013 Jan; 34(4):1246-54. PubMed ID: 23127333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CaCO₃/CaIP₆ composite nanoparticles effectively deliver AKT1 small interfering RNA to inhibit human breast cancer growth.
    Zhou H; Wei J; Dai Q; Wang L; Luo J; Cheang T; Wang S
    Int J Nanomedicine; 2015; 10():4255-66. PubMed ID: 26170662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium carbonate nanoparticle delivering vascular endothelial growth factor-C siRNA effectively inhibits lymphangiogenesis and growth of gastric cancer in vivo.
    He XW; Liu T; Chen YX; Cheng DJ; Li XR; Xiao Y; Feng YL
    Cancer Gene Ther; 2008 Mar; 15(3):193-202. PubMed ID: 18202713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor-C siRNA delivered via calcium carbonate nanoparticle effectively inhibits lymphangiogenesis and growth of colorectal cancer in vivo.
    He XW; Liu T; Xiao Y; Feng YL; Cheng DJ; Tingting G; Zhang L; Zhang Y; Chen YX; Tingting G; Zhang L
    Cancer Biother Radiopharm; 2009 Apr; 24(2):249-59. PubMed ID: 19409048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy.
    Li X; Chen Y; Wang M; Ma Y; Xia W; Gu H
    Biomaterials; 2013 Jan; 34(4):1391-401. PubMed ID: 23164421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.
    Yang XZ; Dou S; Wang YC; Long HY; Xiong MH; Mao CQ; Yao YD; Wang J
    ACS Nano; 2012 Jun; 6(6):4955-65. PubMed ID: 22646867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of small interfering RNA targeting survivin gene on biological behaviour of bladder cancer.
    Hou JQ; He J; Wang XL; Wen DG; Chen ZX
    Chin Med J (Engl); 2006 Oct; 119(20):1734-9. PubMed ID: 17097022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
    Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
    Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer.
    Nogawa M; Yuasa T; Kimura S; Tanaka M; Kuroda J; Sato K; Yokota A; Segawa H; Toda Y; Kageyama S; Yoshiki T; Okada Y; Maekawa T
    J Clin Invest; 2005 Apr; 115(4):978-85. PubMed ID: 15761500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
    Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
    J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfer of siRNA against XIAP induces apoptosis and reduces tumor cells growth potential in human breast cancer in vitro and in vivo.
    Zhang Y; Wang Y; Gao W; Zhang R; Han X; Jia M; Guan W
    Breast Cancer Res Treat; 2006 Apr; 96(3):267-77. PubMed ID: 16341821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
    Yoshizawa T; Hattori Y; Hakoshima M; Koga K; Maitani Y
    Eur J Pharm Biopharm; 2008 Nov; 70(3):718-25. PubMed ID: 18647651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing endosomal escape for nanoparticle mediated siRNA delivery.
    Ma D
    Nanoscale; 2014 Jun; 6(12):6415-25. PubMed ID: 24837409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted polymeric micelles for siRNA treatment of experimental cancer by intravenous injection.
    Christie RJ; Matsumoto Y; Miyata K; Nomoto T; Fukushima S; Osada K; Halnaut J; Pittella F; Kim HJ; Nishiyama N; Kataoka K
    ACS Nano; 2012 Jun; 6(6):5174-89. PubMed ID: 22575090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic cancer therapy by systemic administration of VEGF siRNA contained in calcium phosphate/charge-conversional polymer hybrid nanoparticles.
    Pittella F; Miyata K; Maeda Y; Suma T; Watanabe S; Chen Q; Christie RJ; Osada K; Nishiyama N; Kataoka K
    J Control Release; 2012 Aug; 161(3):868-74. PubMed ID: 22580114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small interfering RNA targeting integrin-linked kinase inhibited the growth and induced apoptosis in human bladder cancer cells.
    Gao J; Zhu J; Li HY; Pan XY; Jiang R; Chen JX
    Int J Biochem Cell Biol; 2011 Sep; 43(9):1294-304. PubMed ID: 21601006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sheddable ternary nanoparticles for tumor acidity-targeted siRNA delivery.
    Yang XZ; Du JZ; Dou S; Mao CQ; Long HY; Wang J
    ACS Nano; 2012 Jan; 6(1):771-81. PubMed ID: 22136582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR siRNA lipid nanocapsules efficiently transfect glioma cells in vitro.
    Resnier P; David S; Lautram N; Delcroix GJ; Clavreul A; Benoit JP; Passirani C
    Int J Pharm; 2013 Oct; 454(2):748-55. PubMed ID: 23583841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multitarget siRNA inhibition of antiapoptotic genes (XIAP, BCL2, BCL-X(L)) in bladder cancer cells.
    Kunze D; Wuttig D; Fuessel S; Kraemer K; Kotzsch M; Meye A; Grimm MO; Hakenberg OW; Wirth MP
    Anticancer Res; 2008; 28(4B):2259-63. PubMed ID: 18751404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.